July 01, 2023
Advance Online
Advance Online
FDA Approves HADLIMA
A fourth biosimilar to Humira is approved for the treatment of plaque psoriasis and PsA.
A fourth biosimilar to Humira is approved for the treatment of plaque psoriasis and PsA.
We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.